SK Biosciences partners with the Gates Foundation to develop RSV preventive antibodies for infants
SK Biosciences has partnered with the Gates Medical Research Institute to develop a new monoclonal antibody aimed at preventing RSV infections in newborns and infants, addressing a leading cause of infant mortality worldwide.
Monoclonal Antibodies Rejected During the Pandemic, How Locatelli Compromises Speranza
Franco Locatelli's recent disclosures reveal that monoclonal antibodies should have been used to protect at-risk groups during the pandemic but were not, casting doubt on the decisions made by health authorities.